JD Health updates share repurchase: 2.25 million shares bought on 19 May; mandate utilisation rises to 0.14%

Bulletin Express

May 19

JD Health International Inc. disclosed that it repurchased 2.25 million ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 41.20 to HKD 41.92. The transaction cost totalled HKD 93.26 million, implying a volume-weighted average price of HKD 41.48 per share.

Including earlier buybacks on 15 May (0.20 million shares) and 18 May (1.91 million shares), shares pending cancellation now stand at 4.35 million, equivalent to 0.14% of the company’s 3.21 billion issued shares.

Under the shareholder mandate approved on 20 June 2025, JD Health is authorised to repurchase up to 320.01 million shares. After the latest transactions, the company has utilised 1.36% of this capacity.

No new shares were issued during the period, and the total number of issued shares remains unchanged at 3.21 billion prior to cancellation of the repurchased stock. A 30-day moratorium on new share issuance or treasury-share transfers is in effect until 18 June 2026, pursuant to Hong Kong Listing Rule 10.06(3)(a).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1105847914"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105847914\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105847914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105847914","market":"us","top_or_hot":-1,"title":"JD Health updates share repurchase: 2.25 million shares bought on 19 May; mandate utilisation rises to 0.14%","media":"Bulletin Express","content":"<p>JD Health International Inc. disclosed that it repurchased 2.25 million ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 41.20 to HKD 41.92. The transaction cost totalled HKD 93.26 million, implying a volume-weighted average price of HKD 41.48 per share.</p>\n<p>Including earlier buybacks on 15 May (0.20 million shares) and 18 May (1.91 million shares), shares pending cancellation now stand at 4.35 million, equivalent to 0.14% of the company’s 3.21 billion issued shares.</p>\n<p>Under the shareholder mandate approved on 20 June 2025, JD Health is authorised to repurchase up to 320.01 million shares. After the latest transactions, the company has utilised 1.36% of this capacity.</p>\n<p>No new shares were issued during the period, and the total number of issued shares remains unchanged at 3.21 billion prior to cancellation of the repurchased stock. A 30-day moratorium on new share issuance or treasury-share transfers is in effect until 18 June 2026, pursuant to Hong Kong Listing Rule 10.06(3)(a).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health updates share repurchase: 2.25 million shares bought on 19 May; mandate utilisation rises to 0.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health updates share repurchase: 2.25 million shares bought on 19 May; mandate utilisation rises to 0.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-19 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. disclosed that it repurchased 2.25 million ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 41.20 to HKD 41.92. The transaction cost totalled HKD 93.26 million, implying a volume-weighted average price of HKD 41.48 per share.</p>\n<p>Including earlier buybacks on 15 May (0.20 million shares) and 18 May (1.91 million shares), shares pending cancellation now stand at 4.35 million, equivalent to 0.14% of the company’s 3.21 billion issued shares.</p>\n<p>Under the shareholder mandate approved on 20 June 2025, JD Health is authorised to repurchase up to 320.01 million shares. After the latest transactions, the company has utilised 1.36% of this capacity.</p>\n<p>No new shares were issued during the period, and the total number of issued shares remains unchanged at 3.21 billion prior to cancellation of the repurchased stock. A 30-day moratorium on new share issuance or treasury-share transfers is in effect until 18 June 2026, pursuant to Hong Kong Listing Rule 10.06(3)(a).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1105847914","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105847914","pubTimestamp":1779199391,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. disclosed that it repurchased 2.25 million ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 41.20 to HKD 41.92. The transaction cost...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康更新股票回购：5月19日买入225万股；授权利用率升至0.14%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. disclosed that it repurchased 2.25 million ordinary shares on 19 May 2026 via on-market transactions at prices ranging from HKD 41.20 to HKD 41.92. The transaction cost totalled HKD 93.26 million, implying a volume-weighted average price of HKD 41.48 per share.\nIncluding earlier buybacks on 15 May (0.20 million shares) and 18 May (1.91 million shares), shares pending cancellation now stand at 4.35 million, equivalent to 0.14% of the company’s 3.21 billion issued shares.\nUnder the shareholder mandate approved on 20 June 2025, JD Health is authorised to repurchase up to 320.01 million shares. After the latest transactions, the company has utilised 1.36% of this capacity.\nNo new shares were issued during the period, and the total number of issued shares remains unchanged at 3.21 billion prior to cancellation of the repurchased stock. A 30-day moratorium on new share issuance or treasury-share transfers is in effect until 18 June 2026, pursuant to Hong Kong Listing Rule 10.06(3)(a).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}